Fingerprint
Dive into the research topics of 'Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo
Brent A. Hanks, Jianghong Jiang, Rana A.K. Singh, Weitao Song, Michael Barry, Mary H. Huls, Kevin M. Slawin, David M. Spencer
Research output: Contribution to journal › Article › peer-review
73
Scopus
citations